AstraZeneca’s new 400 million-dose deal is specifically with France, Germany, Italy and the Netherlands, according to the AP. Those countries are representing the European Commission, and other EU members will have access to the experimental vaccine.
European Union strikes deal for 400 million doses of experimental coronavirus vaccine with drug giant AstraZeneca

Prepare Now Before its too Late
Discover where products are available & compare prices